Ernexa Therapeutics ERNAW Balance Sheet (2010-2026)

NASDAQ ERNAW
$0.04 0.00 (-8.13%)
As of: Sep 4, 2026 · 9:34 AM EDT
Reported Financials

Ernexa Therapeutics Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Ernexa Therapeutics reported total assets of $6.32M and total liabilities of $3.12M for the quarter ended Jun 2026, down 16.7% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
0.21M0.03M0.11M0.17M0.20M
Receivables - Doubtful
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
24.38M16.98M23.50M19.41M13.25M15.54M9.49M5.93M8.65M11.67M9.21M6.68M4.26M1.73M1.92M4.32M3.05M1.88M9.20M5.03M
Receivables - NetNet Receivables
0.68M
Receivables - OtherOther Receivables
0.66M0.83M0.69M0.93M0.03M0.65M0.98M1.78M-1.35M0.35M0.23M0.19M0.25M-0.28M0.15M0.15M-0.06M0.10M0.08M
Receivables
1.35M0.03M-1.35M0.25M-0.06M
Prepaid Assets
1.35M1.10M0.80M1.82M1.67M1.28M0.47M1.07M0.70M1.60M0.70M0.77M0.28M0.19M0.14M0.32M0.18M0.40M0.72M0.78M
Current Assets
25.76M18.77M25.14M21.93M15.85M13.68M6.51M3.89M7.03M9.60M6.16M3.58M4.73M2.35M2.21M4.79M3.38M3.13M10.00M5.89M
Non-Current Assets
Property, Plant & Equipment (Net)
0.55M0.67M0.31M0.42M0.23M0.24M0.21M0.19M0.17M0.49M0.71M0.65M0.10M0.09M0.07M0.05M0.09M0.09M0.09M0.08M
Long-Term Investments
1.00M1.00M0.39M0.09M0.07M0.06M0.01M
Goodwill
2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.00M2.00M
Intangibles
5.99M5.99M6.00M
Goodwill & Intangibles
8.03M8.03M8.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.04M2.00M2.00M
Long-Term Deferred Tax
Other Non-Current Assets
0.52M0.49M0.06M0.48M0.82M4.09M4.09M4.09M4.09M4.10M4.09M4.09M0.12M0.12M0.12M0.12M0.12M0.11M0.11M0.03M
Non-Current Assets
13.64M12.76M10.24M4.98M5.07M8.60M8.59M43.06M45.22M39.53M43.49M42.90M2.99M2.92M2.85M2.79M2.79M2.70M0.55M0.42M
Assets
39.39M31.52M35.38M26.90M20.93M22.28M15.11M46.95M52.25M49.13M49.66M46.49M7.72M5.27M5.06M7.58M6.17M5.83M10.54M6.32M
Liabilities
Current Liabilities
Accounts Payables
1.00M1.75M1.11M1.48M1.15M1.62M1.46M2.67M1.46M1.07M2.06M2.19M2.19M1.72M1.27M1.32M0.96M1.12M1.30M1.38M
Notes Payables
1.75M1.75M4.93M2.25M
Payables
1.00M1.75M1.11M1.48M1.15M3.37M3.21M2.67M1.46M1.07M2.06M2.19M7.12M1.72M3.52M1.32M0.96M1.12M1.30M1.38M
Accumulated Expenses
2.13M1.25M2.38M3.82M3.23M3.63M3.63M2.11M5.02M1.89M1.87M2.39M1.17M1.01M1.35M0.94M0.86M0.90M1.48M1.02M
Other Accumulated Expenses
0.62M0.25M0.04M1.43M2.65M0.59M0.52M0.69M0.58M0.51M0.77M0.51M0.46M0.23M0.46M0.44M0.14M0.58M0.27M0.36M
Short term Debt
0.41M0.04M0.04M0.04M0.04M
Current Leases
0.41M0.43M0.15M0.39M0.44M0.29M0.17M0.17M1.15M2.22M2.87M4.27M0.20M0.21M0.21M0.22M0.21M0.21M0.16M0.17M
Current Taxes
0.01M0.01M0.00M0.00M0.01M0.01M0.02M0.00M0.01M0.01M0.02M0.00M0.00M
Current Deferred Revenue
0.35M0.60M0.19M0.19M5.33M
Total Current Liabilities
4.56M3.68M3.68M7.12M7.47M7.65M5.41M7.17M9.63M6.57M7.77M9.60M9.95M2.94M10.44M2.65M2.14M3.11M3.46M2.93M
Non-Current Liabilities
Capital Leases
0.01M
Non-Current Debt
1.21M0.77M
Convertible Debt
3.45M6.77M8.01M8.89M32.04M
Non-Current Deffered Revenue
0.25M0.25M0.25M0.39M0.34M0.30M
Operating Leases
2.41M2.30M1.02M2.43M2.32M0.89M0.84M34.96M35.00M35.07M36.56M40.31M0.73M0.68M0.63M0.59M0.55M0.49M0.39M0.35M
Non-Current Deferred Tax Liability
Other Non-Current Liabilities
19.36M0.05M13.31M2.52M1.69M0.33M0.38M0.18M0.17M0.12M0.19M0.08M0.04M0.11M0.11M0.11M0.11M0.04M0.04M0.00M
Total Non-Current Liabilities
6.99M5.97M4.75M9.60M10.42M9.84M7.35M42.90M48.52M46.78M52.88M54.93M53.07M3.46M10.90M3.03M2.49M3.39M3.64M3.11M
Total Liabilities
26.35M6.02M18.07M12.12M12.11M10.17M7.73M43.09M48.69M46.90M53.07M55.01M53.11M3.57M11.01M3.14M2.60M3.43M3.68M3.12M
Shareholder's Equity
Total Debt
0.41M2.96M2.52M4.93M2.25M0.04M0.04M0.04M0.04M
Common Equity
31.53M25.50M17.31M14.78M8.81M12.11M7.38M3.87M3.56M2.23M-3.41M-8.53M-45.39M1.70M-5.95M4.44M3.57M2.40M6.86M3.20M
Liabilities and Shareholders Equity
39.39M31.52M35.38M26.90M20.93M22.28M15.11M46.95M52.25M49.13M49.66M46.49M7.72M5.27M5.06M7.58M6.17M5.83M10.54M6.32M
Treasury Shares
914.00
Retained Earnings
-132.74M166.19M167.10M167.97M169.60M177.38M178.07M179.07M184.35M189.19M-193.63M-199.20M-225.80M233.22M-239.74M247.29M247.66M248.03M257.99M258.35M
Preferred Shares
781.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M